山东新华制药股份(00719.HK)：前三季度净利润2.56亿元 同比下降25.53%

Core Viewpoint - Shandong Xinhua Pharmaceutical Co., Ltd. reported a slight increase in revenue but a significant decline in net profit for the first nine months of 2025 compared to the previous year [1] Financial Performance - The company achieved a revenue of 6.763 billion RMB, representing a year-on-year growth of 0.42% [1] - The net profit attributable to shareholders decreased to 256 million RMB, down 25.53% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 239 million RMB, reflecting a decline of 25.62% year-on-year [1] - Basic earnings per share stood at 0.37 RMB [1]